Identification of novel mutations of Insulin Receptor Substrate 1 (IRS1) in tumor samples of non-small cell lung cancer (NSCLC): Implications for aberrant insulin signaling in development of cancer.

Gorgisen G., HAPIL F., YILMAZ O., CETIN Z., PEHLIVANOGLU S., OZBUDAK I., ...Daha Fazla

Genetics and molecular biology, cilt.42, ss.15-25, 2019 (SCI-Expanded, Scopus)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 42
• Basım Tarihi: 2019
• Doi Numarası: 10.1590/1678-4685-gmb-2017-0307
• Dergi Adı: Genetics and molecular biology
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Sayfa Sayıları: ss.15-25
• Anahtar Kelimeler: IRS1, NSCLC, insulin signaling, lung cancer, IRS proteins, GROWTH-FACTOR RECEPTOR, ACTIVATING MUTATIONS, DOWN-REGULATION, PHOSPHORYLATION, EXPRESSION, INSULIN-RECEPTOR-SUBSTRATE-1, PROTEINS, AKT, CHEMOTHERAPY, ASSOCIATION
• Van Yüzüncü Yıl Üniversitesi Adresli: Evet